Table 3.

Patient characteristics and angiographic findings post intravitreal Ranibizumab monotherapy for A-ROP

No	GA	BW	PMA at FA	Eye	PMA of 1st IVR	PMA of 2nd IVR	Fluorescein Angiogram Findings
							Avascular area at zone I (Y/N)	Leakage (Y/N)	Neovascularization (Y/N)
1	24 + 0	510	244	R	32 + 0	41 + 0	Y	Y	Y
				L	32 + 0	41 + 0	Y	Y	Y
2	23 + 0	510	205	R	34 + 0	45 + 0	Y	Y	Y
				L	34 + 0	45 + 0	Y	Y	Y
3	23 + 6	540	206	R	35 + 0	–	N	N	N
				L	35 + 0	–	N	N	N
4	23 + 4	630	209	R	34 + 0	41 + 0	Y	N	N
				L	34 + 0	41 + 0	Y	Y	Y

GA Gestational age, BW Birth weight (grams), PMA Post menstrual age (weeks), R right, L left, Y, yes, N no